Title:
MMP9 AS MARKER FOR ENDOMETRIAL CANCER
Document Type and Number:
Japanese Patent JP2023040246
Kind Code:
A
Abstract:
To provide a biomarker capable of diagnosing early-stage endometrial cancer with high sensitivity and specificity.SOLUTION: The present invention provides a method for diagnosing or prognosing endometrial cancer. The method comprises determining an expression level of MMP9 in a uterine aspirate sample obtained from female reproductive organs. Further, provided is a kit for diagnosis of the disease.SELECTED DRAWING: None
Inventors:
Martinez Garcia, Elena
Coras Ortega, Eva
Gil Moreno, Antonio
Leventos Puccijanet, Jaume
Domon, Bruno
Le Sur, Antoine
Coras Ortega, Eva
Gil Moreno, Antonio
Leventos Puccijanet, Jaume
Domon, Bruno
Le Sur, Antoine
Application Number:
JP2023003700A
Publication Date:
March 22, 2023
Filing Date:
January 13, 2023
Export Citation:
Assignee:
Fundashio Hospital Universitari Bar Devlon-Institute De Reselka
International Classes:
G01N33/574; G01N33/50; G01N33/53; G01N33/68
Attorney, Agent or Firm:
Patent Attorney Corporation Hiroe Associates Patent Office